This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Akio Watanabe: Innovator in Pharmaceutical Development
Introduction
Akio Watanabe is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs targeting specific receptors. His work has the potential to impact the treatment of various diseases.
Latest Patents
Watanabe holds a patent for an EP2 antagonist. This drug contains, as an active ingredient, a compound that exhibits antagonistic activity against an EP receptor. It is designed for the prevention and/or treatment of diseases associated with the activation of this receptor. The patent outlines a specific formula, which includes pharmaceutically acceptable salts.
Career Highlights
Watanabe is associated with Ono Pharmaceutical Co., Ltd., a company known for its innovative approaches in drug development. His work at the company has been instrumental in advancing therapeutic options for patients.
Collaborations
Watanabe has collaborated with notable colleagues, including Atsushi Yoshida and Yasuo Hirooka. Their combined expertise has contributed to the success of various projects within the pharmaceutical sector.
Conclusion
Akio Watanabe's contributions to pharmaceutical innovation, particularly through his patent on an EP2 antagonist, highlight his role as a key figure in the industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile